Y Mehellou, J Balzarini, C McGuigan - ChemMedChem, 2009 - research.birmingham.ac.uk
Prodrug technologies aimed at delivering nucleoside monophosphates into cells (protides) have proved to be effective in improving the therapeutic potential of antiviral and anticancer …
Y Mehellou, J Balzarini, C McGuigan - ChemMedChem, 2009 - cir.nii.ac.jp
Aryloxy Phosphoramidate Triesters: a Technology for Delivering Monophosphorylated Nucleosides and Sugars into Cells | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
Y Mehellou, J Balzarini, C McGuigan - Chemmedchem, 2009 - orca.cardiff.ac.uk
Prodrug technologies aimed at delivering nucleoside monophosphates into cells (protides) have proved to be effective in improving the therapeutic potential of antiviral and anticancer …
Y Mehellou, J Balzarini, C McGuigan - Chemmedchem, 2009 - europepmc.org
Prodrug technologies aimed at delivering nucleoside monophosphates into cells (protides) have proved to be effective in improving the therapeutic potential of antiviral and anticancer …
Y Mehellou, J Balzarini, C McGuigan - ChemMedChem, 2009 - pubmed.ncbi.nlm.nih.gov
Prodrug technologies aimed at delivering nucleoside monophosphates into cells (protides) have proved to be effective in improving the therapeutic potential of antiviral and anticancer …
Y Mehellou, J Balzarini, C McGuigan - Chemmedchem, 2009 - orca.cardiff.ac.uk
Prodrug technologies aimed at delivering nucleoside monophosphates into cells (protides) have proved to be effective in improving the therapeutic potential of antiviral and anticancer …
[引用][C]Aryloxy Phosphoramidate Triesters: A Technology for Delivering Monophosphorylated Nucleosides and Sugars into Cells
Y Mehellou, J Balzarini, C McGuigan - ChemInform, 2010 - Wiley Online Library